RecruitingPhase 3NCT07006675

Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial


Sponsor

Major Extremity Trauma Research Consortium

Enrollment

1,000 participants

Start Date

May 26, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

Two arm, pragmatic, randomized controlled multicenter Phase III noninferiority trial evaluating the efficacy of standard pain management without NSAIDs (Group 1) vs. standard pain management plus up to 6 weeks of NSAIDs (Group 2) in the treatment of tibial shaft fractures.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called 600 mg Ibuprofen for people with pain and tibial fractures. The study is currently recruiting participants at 14 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUG600 mg Ibuprofen

Treatment patients will receive oral ibuprofen 600 mg three times a day (tid) for up to six weeks. Clinicians in this group may use whatever further analgesia they desire, excluding NSAIDs. For patients who have a clinical concern regarding NSAID and prophylactic anticoagulation, the treating physician may consider prescribing misoprostol.


Locations(14)

Eskenazi Hospital

Indianapolis, Indiana, United States

Indiana University-Methodist

Indianapolis, Indiana, United States

University of Maryland R Adams Cowley Shock Trauma Center

Baltimore, Maryland, United States

Harvard Medical Center

Cambridge, Massachusetts, United States

Hennepin Health

Minneapolis, Minnesota, United States

University of Mississippi

Jackson, Mississippi, United States

The MetroHealth System

Cleveland, Ohio, United States

Allegheny General Hospital

Pittsburgh, Pennsylvania, United States

Vanderbilt Medical Center

Nashville, Tennessee, United States

University of Texas Health Science Center - Houston

Houston, Texas, United States

University of Utah

Salt Lake City, Utah, United States

Inova Fairfax Hospital

Falls Church, Virginia, United States

University of Wisconsin

Madison, Wisconsin, United States

University of Calgary, Foothills Medical Centre

Calgary, Alberta, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07006675


Related Trials